跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,075 条关于
“Thymic Stromal Lymphopoietin”
全部
2,075
临床试验
1,639
药物
105
机构
3
资讯
328
去年
Tezspire Demonstrates Success in Phase III Nasal Polyps Trial
2年前
Upstream Bio Secures $200 Million in Series B Funding to Advance UPB-101 for Inflammatory Diseases
去年
Tezspire Shows Promise in Phase III Trial for Nasal Polyps
3个月前
Upstream Bio to Present Novel TSLP Antagonist Verekitug at Goldman Sachs Healthcare Conference
去年
AstraZeneca's Tezspire Shows Positive Phase III Results for Nasal Polyps
去年
Tezspire Meets Endpoints in Phase III Nasal Polyps Trial
去年
Tezspire Meets Co-Primary Endpoints in Phase 3 Trial for Chronic Rhinosinusitis with Nasal Polyps
去年
Upstream Bio Launches Successful IPO, Raising $255 Million for Inflammatory Disease Therapies
去年
AstraZeneca's Tezspire Meets Primary Endpoints in Phase III Trial for Chronic Rhinosinusitis with Nasal Polyps
去年
AstraZeneca's Tezspire Demonstrates Efficacy in Phase III Trial for Chronic Rhinosinusitis with Nasal Polyps
第 1 页，共 33 页
上一页
下一页
